[1] LI Y G, JI D F, ZHONG S, et al. 1-Deoxynojirimycin inhibits glucose absorption and accelerates glucose metabolism in streptozotocin-induces diabetic mice. Sci Rep, 2014, 3(1377):1-12.
[2] PARK S H, KIM J Y, KIM J S, et al. 1, 3-Oxazine as a chiral building block used in the total synthesis of(+)-1-deoxynojirimycin and(2R, 5R)-dihydroxymethyl-(3R,4R)-dihydroxypyrrolidine . Tetrahedron-Asymmetry, 2015, 26(12-13):657-661.
[3] CHALUNTORN V, KIYOTAKA N, PHUMON S, et al. A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect. Food Chem, 2012, 134(4):1823-1830.
[4] DENG C, LIU F, ZENG G Y, et al. Sustained-release effect of Na-montmorillonite on 1-deoxynojirimycin in alkaloid fraction of mulberry leaf extract. Chin Pharm J(中国药学杂志), 2016, 51(8):639-644.
[5] ZHANG F D, LI L. Progress in sodium-glucose co-transporter-2 inhibitors:new drugs for treatment of type 2 diabetes. J Int Pharm Res(国际药学研究杂志), 2011, 38(5):375-380.
[6] BRADBURY F A, MENON K M. Rentention of glucose on oligosaccharide chains linked to the LH/hCG receptor prevents cell surface expression.Biochem and Bioph Res Co, 2001, 282(2):454-462.
[7] LI Y G, LI D F, ZHONG S, et al. Hypoglycemic effect of deoxynojirimycin-polysaccharide on high fat diet and streptozoticin-induced diabetic mice via regulation of hepatic glucose metabolism. Chem-Biol Interact, 2015, 225(6097):70-79.
[8] LI Y G, JI D F, ZHONG S, et al. Hybrid of 1-deoxynojirimycin and polysaccharide from mulberry leaves treat diabetes mellitus by activating PDX-1/insulin-1 signaling pathway and regulating the expression of glucokinase, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase in alloxan-induced diabetic mice. J Ethnopharmacol, 2011, 134(3):961-970.
[9] HYUN J D, JI H C, JI W H, et al. 1-Deoxynojirimycin isolated from Bacillus subtilis improves hepatic lipid metabolism and mitochondrial function in high-fat-fed mice. Food Chem Toxicol, 2014,75(1):1-7.
WANG, G Q, ZHU L, MA M L, et al. Mulberry 1-deoxynojirimycin inhibits adipogenesis by repression of the ERK/PPAR gamma signaling pathway in porcine intramuscular adipocytes . J Agric Food Chem, 2015, 63(27):6212-6220.
TSUDUKI T, KIKUCHI I, KIMURA T, et al. Intake of mulberry 1-deoxynojiri-mycin prevents diet-induced obesity through increases in adiponectin in mice. Food Chem, 2013, 139(1-4):16-23.
LEE S M, HYUN J D, SHIN M J, et al. 1-Deoxynojirimycin isolated from a bacillus subtilis stimulates adiponectin and GLUT4 expressions in 3T3-L1 adipocytes . J Microb Biot, 2013, 23(5):637-643.
HYUN J D, LEE S M, YOUNG S K, et al. Effect of 1-deoxynojirimycin on cholesterol efflux through ABCA1-LXRα pathway in 3T3-L1 adipocytes. J Funct Food, 2014, 7(1):692-699.
SHUANG E, RYO K, TARO H, et al. 1-Deoxynojirimycin attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells. Exp Gerontol, 2014, 55(5):63-69.
YANAKA M, HONMA T, SATO K, et al. Increased monocytic adhesion by senescence in human umbilical vein endothelial cells. Biosci Biotechnol Biochem, 2011, 75(6):1098-1103.
CHAN K C, LIN M C, HUANG C N, et al. Mulberry 1-deoxynojirimycin pleiotropically inhibits glucose-stimulated vascular smooth muscle cell migration by activation of AMPK/RhoB and down-regulation of FAK. J Agric Food Chem, 2013, 61(4):9867-9857.
NAOKI A, HARUHISA K, KENGO O, et al. N-alkylated nitrogen-in-the-ring sugars:conformational basis of inhibition of glycosidases and HIV-1 replication . J Med Chem, 1995, 38(13):2349-2356.
CHANG J H, TIMOTHY M B, GUO J T. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions . Antivir Res, 2013, 99(3):251-260.
CHANG J H, TRAVIS K W, ZHAO X S, et al. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses. Antivir Res, 2013, 98(3):432-440.
ISLAM B, KHAN S N, HAQUE I, et al. Novel anti-adherence activity of mulberry leaves:inhibition of streptococcus mutans biofilm by 1-deoxynojirimycin isolated from morus alba. J Antimicrob Chemoth, 2008, 62(4):751-757.
SENTHIL V, ANDRZEJ P, JONATHAN D L, et al. NagZ triggers gonococcal biofilm disassembly. Sci Rep, 2016, 6:22372. doi:10.1038/srep22372.
BLANCA I T, KARINA F B, JULIO C V, et al. Purification and partial biochemical characterization of a membrane-bound typeⅡ-likeα-glucosidase from the yeast morphotype of Sporothrix schenckii . Abton Leeuw Int J G, 2012, 101(2):313-322.
ERSEK A, XU K, ANTONOPOULOS A, et al. Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease. J Clin Invest, 2015, 125(6):2279-2292.
ZHANG X L, LIU M, XIE P, et al. Specific inhibition effects of N-pentafluorobenzenyl-1-deoxynojirimycin of human CD4+ T cell. Bioorg Med Chem Lett, 2004, 14(14):3789-3792.
LIU M, WANG S R, ZHOU Y D, et al. An iminosugar N-pentafluorobenzyl-1-deoxynojirimycin as a novel potential immunosuppressant for the treatment of Th2-related diseases. Bioorg Med Chem Lett, 2012, 22(1):564-570.
WU X W, ZHANG F Y, ZHU J, et al. N-arylated-lactam-type iminosugars as new immunosuppressive agents: discovery, optimization, and biological evaluation. Chem-Asian J, 2014, 9(8):2260-2271.
KUMAR K S, RATHEE J S, SUBRAMANIAN, et al. Divergent synthesis of 4-epi-fagomine, 3, 4-dihydroxypipecolic acid, and a dihydroxyindolizidine and their β-galactosidase inhibitory and immunomodulatory activities. J Org Chem, 2013, 78(15):7406-7413.
STEPHEN B, PAUL V M. Synthesis of iminosugar derivatives presenting naphythyl and alkylamine interacting groups and binding to somatostatin receptors. Med Chem Commun, 2014, 5(5):1150-1158.
NAKAGAWA K. Studies targeting alpha-glucosidase inhibition, antiangiogenic effects, and lipid modification regulation:background, evaluation, and challenges in the development of food ingredients for therapeutic purposes. Biosci Biotechnol Biochem, 2013, 77(5):900-908.
JIANG Y G, WANG C Y, JIN C, et al. Improved 1-deoxynojirimycin(DNJ) production in mulberry leaves fermented by microorganism. Braz J Microbiol, 2014, 45(2):721-729.